David E. Parkin

6.0k total citations · 1 hit paper
93 papers, 4.3k citations indexed

About

David E. Parkin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, David E. Parkin has authored 93 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Obstetrics and Gynecology, 53 papers in Reproductive Medicine and 17 papers in Surgery. Recurrent topics in David E. Parkin's work include Uterine Myomas and Treatments (38 papers), Endometriosis Research and Treatment (33 papers) and Endometrial and Cervical Cancer Treatments (29 papers). David E. Parkin is often cited by papers focused on Uterine Myomas and Treatments (38 papers), Endometriosis Research and Treatment (33 papers) and Endometrial and Cervical Cancer Treatments (29 papers). David E. Parkin collaborates with scholars based in United Kingdom, Australia and United States. David E. Parkin's co-authors include Kevin Cooper, Martin Gore, Ángel J. Lacave, David Guthrie, Alan N. Gordon, Vanessa N. Harry, Fiona J. Gilbert, Scott I. Semple, Christine Bain and Adrian Grant and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

David E. Parkin

91 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

2001 979 citations David E. Parkin et al. profile →

Peers

Countries citing papers authored by David E. Parkin

Since Specialization

Citations

This map shows the geographic impact of David E. Parkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Parkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Parkin more than expected).

Fields of papers citing papers by David E. Parkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Parkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Parkin. The network helps show where David E. Parkin may publish in the future.

Co-authorship network of co-authors of David E. Parkin

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Parkin. A scholar is included among the top collaborators of David E. Parkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Parkin. David E. Parkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current Approaches to the Management of Patients with Endometrial Cancer 2022 ·Cancers ·Emmanouil Kalampokas, (unknown), (unknown), (unknown), (unknown), (unknown), Olga Triantafyllidou, Mahalakshmi Gurumurthy, David E. Parkin, (unknown), Nikolaos Vlahos	38
2	Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre 2018 ·Anticancer Research ·Emmanouil Kalampokas, (unknown), (unknown), (unknown), David E. Parkin, Mahalakshmi Gurumurthy, (unknown)	11
3	Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation 2012 ·European Radiology ·(unknown), Vanessa N. Harry, Malcolm G. Semple, George Plataniotis, Neil Scott, Fiona J. Gilbert, David E. Parkin	66
4	Use of new imaging techniques to predict tumour response to therapy 2010 ·The Lancet Oncology ·Vanessa N. Harry, Scott I. Semple, David E. Parkin, Fiona J. Gilbert	135
5	Uterine leiomyosarcomas: a review of the diagnostic and therapeutic pitfalls 2007 ·The Obstetrician & Gynaecologist ·Vanessa N. Harry, (unknown), David E. Parkin	18
6	Surgical treatment of bleeding problems in perimenopausal women 2005 ·The Journal of the British Menopause Society ·(unknown), Christine Bain, David E. Parkin	0
7	The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva 2005 ·British Journal of Cancer ·(unknown), I. Douglas Miller, (unknown), (unknown), Linda Sharp, David E. Parkin, Margaret Cruickshank	24
8	Human papillomavirus 16 infection in adenocarcinoma of the cervix 2005 ·British Journal of Cancer ·(unknown), Margaret Cruickshank, Patrick H. Rooney, I.D. Miller, David E. Parkin, G I Murray	22
9	A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: A study by the Scottish Gynaecological Cancer Trials Group (SGCTG) 2005 ·European Journal of Cancer ·Nicholas Reed, (unknown), Robert E. Coleman, David E. Parkin, John D. Graham, Stuart Kaye, J. Ostrowski, Ian D. Duncan, James Paul, A. Hay	12
10	On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma 2004 ·JNCI Journal of the National Cancer Institute ·(unknown), Gordon C. Jayson, Amanda Gordon, Hani Gabra, RE Coleman, (unknown), David E. Parkin, James Paul, (unknown), (unknown)	100
11	Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma 2004 ·JNCI Journal of the National Cancer Institute ·P. Vasey, Gordon C. Jayson, Amanda Gordon, Hani Gabra, Robert L. Coleman, R. Atkinson, David E. Parkin, J. P. Paul, A. Hay, Stuart Kaye, (unknown)	446
12	The impact of the introduction of a fast track clinic on ovarian cancer referral patterns 2003 ·European Journal of Cancer Care ·Orla McNally, (unknown), (unknown), Margaret Cruickshank, David E. Parkin	8
13	A rare case of postmenopausal bleeding due to Wegener's granulomatosis 2002 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), David E. Parkin, (unknown), Premila W. Ashok	8
14	Is outpatient diagnostic hysteroscopy more useful than endometrial biopsy alone for the investigation of abnormal uterine bleeding in unselected premenopausal women? 2002 ·BJOG An International Journal of Obstetrics & Gynaecology ·Christine Bain, David E. Parkin, Kevin Cooper	11
15	Endometrial resection and ablation: past, present and future 2000 ·Gynaecological Endoscopy ·David E. Parkin	6
16	A comparison of bladder and ovarian function two years following hysterectomy or endometrial ablation 1996 ·BJOG An International Journal of Obstetrics & Gynaecology ·Siladitya Bhattacharya, Jill Mollison, S. B. Pinion, David E. Parkin, D. R. Abramovich, (unknown), Henry C Kitchener	58
17	Fatal toxic shock syndrome following endometrial resection 1995 ·BJOG An International Journal of Obstetrics & Gynaecology ·David E. Parkin	25
18	Cervical carcinoma in the Grampian region (1980–1991): a population‐based study of survival and cervical cytology history 1994 ·BJOG An International Journal of Obstetrics & Gynaecology ·Angus D. Macleod, Henry C Kitchener, David E. Parkin, T. K. Sarkar, I. Douglas Miller, Erin Mann, (unknown), Marion Campbell	5
19	Cone biopsy: has endocervical sampling a role? 1992 ·BJOG An International Journal of Obstetrics & Gynaecology ·Deverick J. Anderson, (unknown), David E. Parkin	10
20	Lower Urinary Tract Complications of the Treatment of Cervical Carcinoma 1989 ·Obstetrical & Gynecological Survey ·David E. Parkin	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact